From fighting cancer to flying to Mars, the great minds and talent at Southern Research in Birmingham are providing revolutionary exploration. Southern Research, a not-for-profit 501(c)(3), is a valuable resource to help businesses with everything from material improvement to energy efficiency.
Southern Research has nearly 600 scientists and engineers working across four divisions: Drug Discovery, Drug Development, Engineering, and Energy & Environment.
The institution is developing 18 drugs to combat various forms of cancer, ALS, Alzheimer’s, diabetes, kidney disease, Parkinson’s and tuberculosis, among others. It has already developed 20 other drugs, including seven FDA-approved cancer drugs.
Its other work involves new medical devices, future manned missions to Mars, cleaner air and water, military research and more.
Southern Research does work on behalf of the National Cancer Institute, National Institutes of Health, the U.S. Department of Defense, the U.S. Department of Energy, NASA, hospitals, major aerospace firms, utility companies, and other private and government organizations as we solve the world’s hardest problems.
Alabama Power’s connection to Southern Research dates back to the very beginning. The institution was chartered on October 11, 1941, and Alabama Power CEO Thomas Martin became chairman of the organization in December that same year. Martin gave numerous speeches to various organizations around the South promoting what was then Alabama Research Institute. On May 4, 1944, the Alabama Research Institute’s Board of Trustees voted to change the name to the Southern Research Institute to reflect a more regional focus, and on June 15 the board formally voted to amend the charter and by-laws. By this time, Southern Research had also gained non-profit, tax-exempt status from the U.S. Internal Revenue Service. In August, the institute moved to a two-acre hilltop property in Birmingham.